Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Sirolimus × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Hematologic Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Melanoma 1 Medulloblastoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡